The effect of low dose octreotide administration on renal function and on gene expression of IGF-I axis components in experimental diabetes mellitus

Journal of Endocrinology

Volumn 159, Issue 1, 1998, Pages 133-140

  Rubinger, D ^a   Weiss, O ^a   Zarfati, D ^a   Popovtzer, M M ^a   Raz, I ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; OCTREOTIDE; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DOSE RESPONSE; EXPERIMENTAL MODEL; GENE EXPRESSION; KIDNEY FUNCTION; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DRUG ADMINISTRATION SCHEDULE; GENE EXPRESSION; GENETIC TECHNIQUES; HORMONES; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR I; KIDNEY; MALE; METABOLIC CLEARANCE RATE; OCTREOTIDE; RATS; RATS, INBRED STRAINS; RECEPTOR, IGF TYPE 1; RNA, MESSENGER; SOMATOSTATIN;

EID: 0031721459     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1590133     Document Type: Article

References (43)

1. Bazzoni F & Beutler B 1996 The tumor necrosis factor ligand and receptor families. Review article. New England Journal of Medicine 334 1717-1726.
2. Chomczynski P 1993 A reagent tor the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15 532-535.
3. Doi T, Striker LJ, Quaife C, Conti FG, Ralmiter R, Behringcr R, Brinstek R & Striker GE 1988 Progressive glomerulosclerosis develops in trarisgenic mice chronically expressing growth hormone and growth hormone releasing factor but not those expressing insulin like growth factor I. American Jounial of Pathology 131 398-403.
4. Ezzat S, Ren SB, Graunstein GD & Melmed S 1991 Octreoride stimulates insulin-like growth factor binding protein 1 (IGFBP1) levels in acromegaly. Journal of Clinical Endocrinology and Metabolism 73 441-443.
5. Fagin JA, Roberts CT Jr, Le Roith D & Brown AT 1989 Coordinate decrease of tissue insulin-like growth factor I posttranscriptional alternative mRNA transcripts in diabetes mellitus. Diabetes 38 428-438.
6. Flyvbjerg A, Thorlacius-Ussing O, Naeraa R, Ingerslev J & Ørskov H 1988 Kidney tissue somatomedin C and initial renal growth in diabetic and uninephrectomized rats. Diabetologia 31 310-314.
7. Flyvbjerg A, Frystyk J, Thorlacius-Ussing O & Ørskov H 1989 Somatostatin analogue administration prevents increase in kidney somatomedin C and initial renal growth in diabetic and uninephrectomized rats. Diabetologia 32 261-265.
8. Flyvbjerg A, Bornfeldt KE, Marshall SM, Arnqvist H & Ørskov H 1990 Kjdney IGF-I mRNA in initial renal hypertrophy in experimental diabetes mellitus. Diabetologia 33 334-338.
9. Flyvbjerg A, Bonifeldt KE, Ørskov H & Arnqvist HJ 1991 Effect of insulin-like growth factor I infusion on renal hypertrophy in experimental diabetes mellitus in rats. Dialietobgia 34 715-720.
10. Flyvbjerg A, Marshall SM, Frystyk J, Hansen KW, Harns AG & Ørskov H 1992 Octreotide administration in diabetic rats: effect on renal hypertrophy and urine albumin excretion. Kidney International 41 805-812.
11. Fredstorp L, Werner S, Bang P & Hall K 1994 inverse correlation between insulin-like growth factor binding protein-1 and insulin in patients with acromegaly during treatment with the somatostatin analogue octreotide. Clinical Endocrinology 41 499-501.
12. Grenbaek H, Nielsen B, Frystyk J, Ørskov H & Flyvbjerg A 1995a Effect of octreotide on experimental diabetic renal and glomerular growth: importance of early intervention. Journal of Endocrinology 147 95-102.
13. Grønbaek H, Nielsen B, Østerby R, Harris A, Ørskov H & Flyvbjerg A 1995b Effect of octreoride and insulin on manifest renal and glomerular hypertrophy and urinary albumin excretion in long term experimental diabetes in rats. Diabetologia 38 135-144.
14. Guler HP, Zapf J, Scheiwiller E & Froesch ER 1988 Recoinbinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proceedings of the National Academy of Sciences of the USA 85 4889-4893.
15. Guler HP, Schmid C, Zapf J & Froesch ER 1989 Effects of recombinant IGF-I on insulin secretion and renal function in normal human subjects. Proceedings of the National Academy of Sciences of the USA 86 2868-2872.
16. Ipp E, Sinai Y, Bar-Oz B, Nesher R & Cerasi E 1987 Somatostatin impairs clearance of exogenous insulin in humans. Diabetes 36 673-677.
17. Jensen PK, Sandahl-Christiansen J, Steven K & Parving HH 1981 Renal function in streptozotocin-diabetic rats. Diabetologia 21 409-414.
18. Karalis K, Mastorakos G, Chrousos GP & Tolis G 1994 Somatostatin analogues suppress the inflammatory reaction in vivo. Journal of Clinical Investigation 93 2000-2006.
19. Kollind M, Moberg E, Lins PE & Adamson U 1990 Exogenous somatostatin raises plasma insulin levels in patients with insulin dependent diabetes melutus. Hormone and Metabolic Research 22 581-583.
20. Krempf M, Ranganathan S, Remy JP, Charbannel B & Guillon J 1990 Effect of long acting somatostatin analog (SMS-201-995) on high glomenilar filtration rate in insulin dependent diabetic patients. International Journal of Clinical Pharmacology, Therapy and Toxicology 28 309-311.
21. Lamberts SWJ, van der Lely A-J, de Herder WW & Hofland LJ 1996 Octreotide. New England Journal of Medicine 334 246-254.
22. Landa JI, Alvarez Sanchez J, Grau M, Sanchez JA & Balibrea JL 1995 Somatostatin reduces the levels of tumor necrosis factor alpha in a rat model of endotoxemia induced by lipopolysaccharide. Research in Experimental Medicine 195 317-325.
23. Landau D, Chin E, Bondy C, Domene H, Roberts CT Jr, Grønbaek H. Flyvbjerg A & Le Roith D 1995 Expression of insulin-like growth factor binding proteins in the rat kidney: effects of long-term diabetes. Endocrinology 36 1835-1842.
24. Lowe WL Jr, Roberts CT Jr, Lasky SR & Le Roith D 1987a Differential expression of alternative 5′ untranslated regions in mRNAs encoding rat insulin-like growth factor I. Proceeding of the National Academy of Sciences of the USA 84 8946-8950.
25. Lowe WL Jr, Schaffner AE, Roberts CT Jr & Le Roith D 1987b Developmental regulation of somatostatin gene expression in brain is region specific. Molecular Endocrinology 1 181-187.
26. Lowe WL Jr, Lasky SR, Le Roith D & Roberts CT Jr 1988 Distribution and regulation of rat insulin-like growth factor I mRNA encoding alternative carboxyterminal E peptides: evidence for differential processing and regulation in liver. Molecular Endocrinology 2 526-535.
27. Muntzel M, Hannedouche T, Niesor R, Noel LH, Souberbielle JC, Lacour B & Drücke TT 1992 Long term effects of a somatostatin analogue on renal hernodynamics and hypertrophy in diabetic rats. Clinical Science 83 575-581.
28. Ørskov H, Flyvbjerg A & Frystyk J 1992 Octreotide and diabetes: theoretical and experimental aspects. Metabolism 41 (Suppl 2) 66-71.
29. Ørskov H, Wolthers T, Grøfte T, Flyvbjerg A, Vilstrup H & Hamberg O 1994 Somatostatin stimulated insulin-like growth factor binding protein 1 release is abolished by hyperinsulinemia. Journal of Clinical Endocrinology and Metabolism 78 138-140.
30. Parving HH, Østerby R, Anderson PW & Hsue WA 1996 Diabetic nephropathy. In The Kidney, ch 39, pp 1864-1892. Eds BH Brenner & FC Rector. Philadelphia, London, Toronto, Montreal, Sydney, Tokyo: WB Saunders Co.
31. Patel YC, Greenwood M, Panetta R, Hukovic N, Grigorakis S, Robertson L-A & Srikant CB 1996 Molecular biology of somatostatin receptor subtypes. Metabolism 45 31-38.
32. Phillip M, Werner H, Palese T, Kowarski AA, Stannard B, Bach LA, Le Roith D & Roberts CT Jr 1994 Differential accumulation of insulin-like growth factor I in kidneys of pre-and postpubertal streptozotocin-diabetic rats. Journal of Molecular Endocrinology 12 215-224.
33. Robinier D, Weiss O, Nepbesh I, Moshe R, Popovtzer MM & Raz I 1994 Intrarenal insulin growth factors I (IGF-I) axis components gene expression in experimental diabetes mellitus. Journal of the American Society of Nephrology 5 971.
34. Schulkes A 1994 Somatostatin: physiology and clinical applications. In Baillière's Clinical Endocrinology and Metabolism, vol 8, no. 1, pp 215-230. Eds P Fuller & A Shulkes. London, Philadelphia, Sydney, Tokyo, Toronto: WB Saunders Co.
35. Serri O, Beauregard H, Brazeau P, Abribat T, Lambert J, Harris A & Vachon L 1991 Somatostatin anafogue, octreotide, reduces increased glomerular filtration rate and kidney size in insulin dependent diabetes. Journal of the American Medical Association 265 888-892.
36. Serri O, Beauregard H, Kachra Z & Posner B 1992 Octreotide inhibits insulin-like growth factor 1 hepatic gene expression in the hypophyectomized rat: evidence for a direct and indirect mechanism of action. Endocrinology 130 1816-1821.
37. Seyer-Hansen K 1976 Renal hypertrophy in streptozotocin diabetic rats. Clinical Science and Molecular Medicine 51 551-553.
38. Steer KA, Sochor M, Kunjara S, Doepfner W & McLean P 1988 The effect of Somatostatin analogue (SMS 201-995, Sandostatin) on the concentration of phosphoribosyl pyrophosphate and the activity of the pentose phosphate pathway in the early renal hypertrophy of experimental diabetes in the rat. Biochemical Medicine and Metabolic Biology 39 226-233.
39. Tsuzaki S & Moses AC 1990 Somatostatin inhibits deoxyribonucleic acid synthesis induced by both thyrotropin and insulin-like growth factor 1 in FRTL5. Endocrinology 126 3131-3138.
40. +-ATPase activity. Pflügers Archiv 401 97-100.
41. Werner H, Woloschak M, Adamo M, Shen-Orr Z, Roberts CT Jr & Le Roith D 1989 Developmental regulation of the rat insulin-like growth factor I receptor gene. Proceedings of the National Academy of Sciences of the USA 88 7451-7455.
42. Wilding PH, Ghatei MA & Bloom SR 1995 Hormones of the gastrointestinal tract. In Endocrinology, pp 2870-2894. Ed LJ De Groot. Philadelphia, London, Toronto, Montreal, Sydney, Tokyo: WB Saunders Co.
43. Yousefi S, Vaziri N, Carandang G, Le W, Yamamoto R, Granger G, Ocariz J & Cesario T 1991 The paradoxical effects of somatostatin on the bioactivity and production of cytotoxins derived from human peripheral blood mononuclear cells. British Journal of Cancer 64 243-246.